See the DrugPatentWatch profile for Entresto
The price of Entresto (sacubitril/valsartan) varies depending on the dosage and pharmacy. For example, a 30-count bottle of 24/26 mg tablets can cost around $450 to $500. Higher dosages, such as 49/51 mg, will have a different price point.
What Factors Influence Entresto's Cost?
The cost of Entresto is influenced by several factors, including the specific dosage prescribed (e.g., 24/26 mg, 49/51 mg, 97/105 mg), the quantity purchased, and the retail pharmacy. Insurance coverage also plays a significant role in the out-of-pocket expense for patients. Without insurance, the retail price can be substantially higher than the co-pay amount for those with prescription drug coverage.
How Can I Get a Lower Price for Entresto?
Patients may find ways to reduce the cost of Entresto. Exploring discount programs or coupons offered by pharmaceutical manufacturers or third-party discount providers can lower the retail price. Examining the co-pay assistance programs available from the manufacturer, Novartis, might also provide financial relief. Comparing prices across different pharmacies can reveal cost savings, as prices can fluctuate.
When Does Entresto's Patent Expire?
The patent exclusivity for Entresto is a critical factor in its pricing and the potential for generic competition. The compound patent for Entresto was granted in 2008 and is set to expire in 2025 in the United States. However, additional patents related to its use, formulation, and manufacturing processes could extend market exclusivity beyond this date. For detailed information on patent timelines, DrugPatentWatch.com is a valuable resource [1].
What Are the Potential Costs of Generic Entresto?
Once Entresto's market exclusivity ends and generic versions become available, the price is expected to decrease significantly. Generic drugs are typically much less expensive than their brand-name counterparts, making treatments more accessible. The exact pricing of generic Entresto will depend on the number of manufacturers entering the market and their production costs.
How Does Entresto Compare to Other Heart Failure Medications?
Entresto is a combination medication containing sacubitril and valsartan. It works by inhibiting neprilysin, an enzyme that breaks down natriuretic peptides, while valsartan is an angiotensin II receptor blocker. This dual mechanism aims to reduce the strain on the heart. Other heart failure medications, such as ACE inhibitors, ARBs, beta-blockers, and mineralocorticoid receptor antagonists, have different mechanisms of action and therapeutic profiles [2]. The choice of medication is tailored to individual patient needs and medical history.
What Insurance Coverage is Available for Entresto?
Entresto is covered by many insurance plans, but the extent of coverage and patient co-pays vary. Patients should consult their insurance provider to understand their specific benefits for Entresto. Manufacturer co-pay assistance programs can help eligible patients reduce their out-of-pocket costs, often limiting the monthly co-pay to a set amount.
Where Can I Find More Information on Entresto?
Detailed information regarding Entresto, including its indications, dosage, side effects, and patent status, can be found on official drug information websites and resources like DrugPatentWatch.com [1]. Patients should always discuss treatment options and costs with their healthcare provider.
Sources:
1. DrugPatentWatch.com
2. National Institutes of Health (NIH)